Beam Therapeutics (BEAM) Shares Issued (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Shares Issued data on file, last reported at $1.5 million in Q1 2026.

• Quarterly Shares Issued rose 0.6% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9000.0 (down 99.67% YoY) and the FY2024 annual result came in at $2.6 million, down 13.56% from the prior year.
• Shares Issued advanced to $1.5 million in Q1 2026 per BEAM's latest filing, from -$2.9 million in the prior quarter.
• Across five years, Shares Issued topped out at $106.3 million in Q4 2022 and bottomed at -$92.3 million in Q2 2023.
• The 5-year median for Shares Issued is $1.4 million (2025), against an average of $7.7 million.
• The widest annual swing landed in 2023, when Shares Issued surged 6555.88%; it then sank 288500.0% in 2025.
• Tracing BEAM's Shares Issued over 5 years: stood at $106.3 million in 2022, then sank by 102.21% to -$2.4 million in 2023, then surged by 99.96% to -$1000.0 in 2024, then slumped by 288500.0% to -$2.9 million in 2025, then jumped by 152.32% to $1.5 million in 2026.
• Per Business Quant, the three latest BEAM Shares Issued figures stand at $1.5 million (Q1 2026), -$2.9 million (Q4 2025), and $1.4 million (Q3 2025).

Peer Comparison